You can find more information on domperidone in The Newman-Goldfarb protocols.
Domperidone was initially prescribed for people with upper gastrointestinal problems. It was discovered to have a side effect that results in prolactin levels that could in turn cause lactation. A similar drug called Reglan is used in the U.S. to induce lactation, however, it is not recommended for long-term use in lactating women.
This page contains product information about the drug domperidone, including dosage recommendations, possible side effects and FDA regulations, and what Dr. Thomas Hale says about domperidone in his book "Medications and Mother’s Milk, 2002", Pharmasoft Publishing, p. 230
Dosage instructions for domperidone.
Newman-Goldfarb Protocols for Induced Lactation © 2002-2010
Jack Newman, MD, FRCPC and Lenore Goldfarb, PhD, CCC, IBCLC, ALC
If you value this service, kindly consider a donation to the Canadian Breastfeeding Foundation (registered charity) and earmark the donation for the International Breastfeeding Centre (Newman Breastfeeding Clinic) and/or the Goldfarb Breastfeeding Program.
You can donate through their website, canadianbreastfeedingfoundation.org, or by mail to Canadian Breastfeeding Foundation, 5764 Monkland Ave, Suite 424, Montreal, Quebec, Canada, H4A 1E9.
© 2002-2017 Dr. Lenore Goldfarb, PhD, CCC, IBCLC, ALC and contributing authors to AskLenore.info. All rights reserved.
Disclaimer: All material provided in asklenore.info is provided for educational purposes only. Consult your physician regarding the advisability of any opinions or recommendations with respect to your individual situation.